Clinical Trials Logo

Filter by:
NCT ID: NCT04622748 Recruiting - Covid-19 Clinical Trials

Neurocognitive Functions of Recovered COVID-19 Patients

Start date: July 10, 2020
Phase:
Study type: Observational

This study is carried on in Wuchang Hospital in Wuhan, China. The investigators plan to recruit 80 patients with COVID-19 and 80 matched healthy control. Using the design of case-control study, the study aims to assess the neurocognitive functions such as executive function and attentional bias in recovered patients with COVID-19 under normal and stress conditions, and to analyze the influencing factors of neurocognitive functions, such as mental health conditions, inflammation indicators and cardiopulmonary function.

NCT ID: NCT04622579 Recruiting - Clinical trials for Diffuse Large B Cell Lymphoma

Lenalidomide Combined With Rituximab as Front-line Therapy for DLBCL Patients Aged Over 80 Years

R2DLBCL80
Start date: October 23, 2020
Phase: Phase 2
Study type: Interventional

About 40% of Diffuse large B cell lymphoma relapse or is refractory, age is a prognostic factor of DLBCL, as elderly patients are not capable to received standard treatment, the prognosis of elderly patients is poor especially those aged over 80 years. In this study,we aimed to investigate the safety and efficacy of the combination of lenalidomide and rituximab in elderly patients aged ≥ 80 years with untreated DLBCL.

NCT ID: NCT04622475 Recruiting - Clinical trials for Steroid-refractory Gastrointestinal Acute Graft Versus Host Disease

Efficacy and Safety of FMT Capsule Treating Steroid-refractory GI-aGvHD

Start date: November 2020
Phase: N/A
Study type: Interventional

Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD) is a complication of allogeneic stem cell transplant which is usually treated with steroids. When aGVHD does not respond to steroids it is described as steroid-refractory aGVHD. There is no standard therapy for steroid-refractory GI-aGVHD. Fecal Microbiota Transplantation (FMT) is the transfer of fecal material from a healthy donor to a patient in order to restore the diversity of the intestinal microbiota. FMT is currently indicated for the treatment of recurrent Clostridium Difficile infection. The investigators hypothesize that perturbations in the intestinal microbiota following allogeneic hematopoietic stem cell transplantation (HSCT) are essential for the development and propagation of acute graft-versus-host disease. Therefore, modification of HSCT recipients' gut microbiota using fecal transplantation from a healthy donor could be used to treat gut acute GVHD. This study evaluates safety and feasibility of fecal microbiota transplantation with frozen capsules from healthy donors for the treatment of steroid resistant or steroid dependent acute graft-versus-host disease of the gut.

NCT ID: NCT04622124 Recruiting - Hyperuricemia Clinical Trials

A Safety and Tolerability Study of FCN-207 in Healthy Volunteers

Start date: November 11, 2020
Phase: Phase 1
Study type: Interventional

This research study is studying an investigational drug called FCN-207 in healthy adult males or females.

NCT ID: NCT04621981 Recruiting - Clinical trials for Sepsis, Septic Shock

Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis

Start date: March 11, 2021
Phase: N/A
Study type: Interventional

At present, people still have different opinions on choosing which kind of crystalloid solution for patients with sepsis, and there is no unified standard yet. It is necessary to conduct systematic studies on comparison of different fluid resuscitation methods on the efficacy and safety of crystalloid solution for patients with sepsis. Therefore, this study focuses on the efficacy and safety of sodium bicarbonate Ringer's solution compared with normal saline.

NCT ID: NCT04621565 Recruiting - Surgery Clinical Trials

Hydrocortisone Use During Peri-operation for Pituitary Adenomas

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The investigators hypothesize that withholding hydrocortisone during the peri-operation in patients with pituitary adenomas whose hypothalamus pituitary adrenal axis are intact are safe.

NCT ID: NCT04621305 Recruiting - Emergence Delirium Clinical Trials

Remimazolam Reduces Emergence Delirium in Preschool Children Undergoing Laparoscopic Surgery by Sevoflurane Anesthesia

Start date: November 21, 2020
Phase: Phase 4
Study type: Interventional

Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The use of sevoflurane has been identified as one of the most important risk factors. In the investigators' study,the researchers conducted the current study to investigate whether remimazolam can reduce incidence of ED.

NCT ID: NCT04620837 Recruiting - Clinical trials for Small Cell Lung Carcinoma

Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy

Start date: November 1, 2020
Phase: Phase 2
Study type: Interventional

To show that maintenance therapy with Tislelizumab plus Anlotinib will prolong Progression Free Survival in subjects with extensive stage disease small cell lung cancer who have completed first line chemotherapy.

NCT ID: NCT04620655 Recruiting - Clinical trials for T Acute Lymphoblastic Leukemia

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

Start date: November 15, 2020
Phase: N/A
Study type: Interventional

This study is designed to explore the safety of RD13-01 for patients with CD7+ relapsed and/or refractory T cell acute lymphoblastic leukemia or lymphoblastic lymphoma. And to evaluate the efficacy and pharmacokinetics of RD13-01 in patients.

NCT ID: NCT04620577 Recruiting - Clinical trials for The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice

The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice

Start date: October 20, 2020
Phase:
Study type: Observational

To investigate the influence of antibiotics on the incidence of biliary tract infections after PTCD for malignant obstructive jaundice.